Business is business. Maybe it's about making a difference in the world of consumers but mostly, it's about making money. I get that -- and if I owned my own company and offered some sort of product, surely my goal would be to reap a financial reward. And if I wanted to increase my reward, I guess I would consider new markets, new advertising, and new techniques for hauling in loads of cash.

So I see what's going on with the new Camel No. 9 cigarettes, in their hot-pink fuscia and minty-teal green packages with the slogan Light and Luscious. I understand this brand is targeting female smokers with enticing wording that Camel maker R.J. Reynolds executives say is meant to suggest dressed to the nines, putting on your best. I even get that it's a pretty savvy strategy. But somehow, it all seems so wrong.

In a world where more women die of lung cancer than breast cancer -- by a large margin -- how can anyone, even business people whose sights are set on profits, feel OK with the decision to encourage women to smoke?

Think about these passages that just recently published in a New York Times article:

Wall Street analysts praise the introduction of Camel No. 9, in regular and menthol flavors, as a further step by the R. J. Reynolds, a unit of Reynolds American, toward a new marketing strategy. The goal is to refocus on the biggest, most popular -- and most profitable -- brands, which include Kool as well as Camel.

"What we're about is giving adult smokers a choice," says one executive, "with products we believe are more appealing than existing products." The introduction of Camel No. 9 is part of plans to "focus on products that are 'wow,' " she added, "that add fun and excitement to the category."

Fun and excitement? Believe me, there's nothing fun and exciting about cancer. Now if I could only package that truth and market it to the world. I suspect I'd be a rich woman -- and I don't mean financially.

My gut hasn't always guided me through life's most difficult decisions and dilemmas. It wasn't until I felt a lump in my breast more than two years ago that my gut kicked into gear and told me something very important.

"It's cancer," my insides told me one week before the surgeon who did my biopsy called.

"It's cancer," the surgeon said. I didn't tell him, but I thought it: "I know."

I also knew prior to surgery that my cancer had not spread to my lymph nodes. My gut told me this too. It also told me the chemotherapy drug Taxol was not right for me -- since my cancer had not spread -- despite the urging of one oncologist that I accept this treatment. I would have gone on gut instinct alone in my rejection of this medication but another doctor weighed in and agreed with my gut, so I had solid backing on this decision.

Many have dismissed hunches like these and have written off those who believe in them as screwballs, says writer Chip Brown in the March 2007 issue of The Oprah Magazine. But as Brown shares after peering into the world of gut instinct, there are 100 million nerve cells in the gut. They run on autopilot, regulate digestion, play a critical role in the body's immune system, and control mood-altering neurotransmitters identical to those in the brain.

The gut is essentially a second brain. It was a "gut feeling" that led Fred Smith, founder of Federal Express, to begin exploring the possibilities of overnight delivery and Howard Schultz, founder of Starbucks, to begin mass marketing coffee. Wall Street professionals make millions on their gut feelings, sportscasters make startling predictions based on gut guidance, and entrepreneurs launch thriving businesses because of the inklings that rumble in their tummies.

You may or may not be a gut thinker yourself. But I've stumbled upon a gut exercise -- thanks to psychotherapist Nancy Napier --and I'd like for you to consider it the next time you find yourself stuck at a crossroads, unsure of where to turn. You never know, the direction you seek may be swirling around in your midsection, just waiting for a call to action.

Think about this:

You are wavering between two choices. Find yourself a quiet, serene place where there will be no disruptions. Now sit down. Take a moment to settle and focus on the issue you want to explore. Then choose one side. Think about this side and notice what happens in your gut. Do you feel a tightening and gripping or a softening and warming? Are the sensations pleasant or uncomfortable? Notice your thoughts. Are they positive or negative? Give yourself some time to feel your gut and your mind responding.

Now shift to the other side. Think about the previous questions, and try to chart what your body gut is saying.

While you may not get a gut answer at first, if you come back with the question several times, you'll likely hear just what your gut wants you to know.

Nabilone, known as Cesamet, a synthetic imitation of an active ingredient found in marijuana, has been shown successful in treating cancer patients experiencing nausea, pain, anxiety and depression, according to University of Toronto researchers who conducted a study on the effectiveness of the synthetic drug.

During the study of 139 participants, a survey was conducted to rate how well the synthetic drug alleviated the adverse side-effects most commonly associated with chemotherapy. According to the study, cancer patients who were prescribed Cesamet indicated less pain, anxiety and depression.

A prescription drug approved for cancer patients who do not respond to traditional anti-nausea treatments, lead investigator Dr. Vincent Maida stated, "This is not a pot pill and has absolutely no street value."

The trouble with the synthetic drug, which is legal, is the stigma attached to marijuana use in general, even on the part of some physicians, who are said to be hesitant to prescribe a version of marijuana even if it is not marijuana. In our modern society, marijuana is sometimes associated with counter-culture populations, addiction and even as a gateway to more addictive drugs.

I would say I just do not get it when it comes to the denial of making cancer treatment for a cancer patient a little easier, but The Scientific American published a brief history of marijuana that brings us from ancient China to the present with, "In 1937 the U.S. Congress, against the advice of the American Medical Association, passed the Marijuana Tax Act, effectively banning use of the drug by making it expensive and difficult to obtain. Ever since, marijuana has remained one of the most controversial drugs in American society. Despite efforts to change its status, it remains federally classified as a Schedule 1 drug, along with heroin and LSD, considered dangerous and without utility."

As anyone who has undergone the grueling ordeal of chemotherapy can tell you, getting high is the last thing on their mind. However, alleviating the debilitating side effects of chemotherapy is critical.

Other medical marijuana-related posts include:

• Montel Williams: poster child for pot
  
• Medical marijuana pot pill approved for chemotherapy
• Breast cancer has made me a criminal patient story
• FDA rejects medical marijuana use
• Guru of Ganja: medical marijuana advocate faces new pot charges

Medical marijuana advocate Ed Rosenthal has been indicted again by a federal grand jury on a number of counts including conspiracy to manufacture and distribute marijuana; money laundering and filing false tax returns related to a marijuana operation.

This is not the first time Rosenthal has been brought up on charges involving medical marijuana activities. Three years ago, he was convicted for cultivating marijuana for a city of Oakland medical marijuana program. An appeals court overturned the conviction this past April, citing jury misconduct, but it upheld federal powers to charge marijuana growers.

The Ask Ed columnist for High Times magazine Rosenthal, 61, known as the Guru of Ganja and author of marijuana cultivation books, is quoted as saying, "What they're trying to show is that they can close down anybody, a legitimate club, a legitimate provider who's sanctioned by the city. They're trying to stop patients from getting their medicine."

Other medical marijuana-related posts include:

• Montel Williams: poster child for pot
  
• Medical marijuana pot pill approved for chemotherapy
• Breast cancer has made me a criminal patient story
• FDA rejects medical marijuana use

Medical use of marijuana on a doctor's recommendation is legal in a number of states but prohibited by federal law.

I like to read. I just don't find much time to do it -- with two kids, two jobs, an unpredictable exercise schedule, endless medical appointments, and all the other craziness that accompanies life. I would like to find more time for books -- books a bit more complex than the one I found time to read at bedtime tonight about a frog and a toad who spend their days flying kites and enjoying picnics together. I would like to read books that capture relationships and life experiences and a bit of mystery too.

The last book I read -- The Shop on Blossom Street -- is the kind of book I like. It is easy to read and captivating and inspiring and comforting. It is the kind of book I want to keep reading -- long after I have to put it down to tend to distractions. Perhaps it's the thread of cancer woven into the storyline of this book that kept me wanting more.

The Shop on Blossom Street -- by Debbie Macomber -- follows four women who are all seeking change in their lives. The lead character opens a yarn shop, years after a cancer diagnosis and with the intention of moving forward despite an uncertain future. She hosts knitting classes and forms relationships with three other women in search of brighter days.

Character Lydia Hoffman -- the cancer survivor -- overcomes obstacles and challenges and even another cancer scare. She finds friendship and love and all sorts of unexpected discoveries. She even graces the pages of a second book -- A Good Yarn -- that follows her continued life journeys.

I have the book A Good Yarn. It's on my bookshelf. And I can't wait to read it. I just can't find the time.

Is overcoming the fear of the boogie man by using a night light, putting us at a higher risk to get cancer? A good night's sleep in total darkness might aid in reducing cancer risks. The hormone melatonin, which is secreted by the pineal gland in the brain and plays an important role in the body's sleep cycle, is thought to influence the secretion of estrogen, which in turn influences breast cancer risk.

Melatonin is produced after the body is subjected to sunlight during the day and then while you are asleep in total darkness with no lights interfering with the brain waves, it is produced. It is only produced when your body is in complete darkness. Research found that totally blind women had a 36 percent lower risk of breast cancer compared with sighted women.

According to additional research, women who work regular night shifts have a higher risk of colon cancer. "While this finding needs to be replicated in future studies, the data is beginning to show that it may be melatonin, not estrogen, that is influencing cancer risk," researcher Dr Eva Schernhammer said. "If melatonin's anti-cancer properties are the source of our observed effects, this research opens a whole new arena of potential associations between exposure to light and a variety of cancers."

Studies show that sleeping with a night light, television on, or light from street lights peering through bedroom windows, reduces melatonin levels in the body. Experts are also evaluating the possible link between childhood leukemia and too much light at night. Several studies have concluded that people who work at night are more likely to develop breast cancer.

It is suggested that no night lights be used, televisions be turned off, and that shades and dark curtains be used to block outside street or security lighting from entering the room you sleep in so that your brain waves will not be affected and your body will produce melatonin naturally.

Louis Rukeyser, host of the television program Wall Street Week With Louis Rukeyser, passed away yesterday after a long struggle with multiple myeloma, a rare bone marrow cancer. A financial journalist known for his dry wit and common sense jargon-less approach to financial matters, he gained an enormous following of loyal fans over the years. Rukeyser demystified the economic and financial world for millions as a television show host, columnist and author. PEOPLE described him as the only sex symbol of the dismal science of his field. Louis Rukeyser died peacefully at home in Greenwich, Connecticut. He was 73.